# Human Papillomavirus Vaccine Safety & Immunogenicity Trial in Healthy Young Adult Women With HPV Vaccine (GSK1674330A)

> **NCT00478621** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 540 (actual)

## Conditions studied

- Infections, Papillomavirus

## Interventions

- **BIOLOGICAL:** GSK Biologicals' HPV vaccine (GSK1674330A)
- **BIOLOGICAL:** Cervarix TM

## Key facts

- **NCT ID:** NCT00478621
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05-25
- **Primary completion:** 2008-06-30
- **Final completion:** 2008-10-13
- **Target enrollment:** 540 (ACTUAL)
- **Last updated:** 2017-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00478621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00478621, "Human Papillomavirus Vaccine Safety & Immunogenicity Trial in Healthy Young Adult Women With HPV Vaccine (GSK1674330A)". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00478621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*